Fangfang Shi
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology top 10%
- Immunology
- Biomedical Engineering
- Topics
- Immunotherapy and Immune Responses (11 papers)Cancer Cells and Metastasis (10 papers)Nanoparticle-Based Drug Delivery (7 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Fangfang Shi
64 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 117
- Molecular Biology 838
- Cancer Research 536
- Oncology 322
- Immunology 158
- Biomedical Engineering 119
Countries citing papers authored by Fangfang Shi
This map shows the geographic impact of Fangfang Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfang Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfang Shi more than expected).
Fields of papers citing papers by Fangfang Shi
This network shows the impact of papers produced by Fangfang Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfang Shi. The network helps show where Fangfang Shi may publish in the future.
Co-authorship network of co-authors of Fangfang Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Fangfang Shi. A scholar is included among the top collaborators of Fangfang Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangfang Shi. Fangfang Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 8 | |
| 4 | 50 | |
| 5 | 68 | |
| 6 | 25 | |
| 7 | 7 | |
| 8 | 6 | |
| 9 | 4 | |
| 10 | 5 | |
| 11 | 11 | |
| 12 | 6 | |
| 13 | 21 | |
| 14 | 6 | |
| 15 | 34 | |
| 16 | 27 | |
| 17 | 15 | |
| 18 | 28 | |
| 19 | 72 | |
| 20 | 7 |
About Fangfang Shi
Fangfang Shi is a scholar working on Hematology, Oncology and Cancer Research, having authored 66 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Cancer Cells and Metastasis (10 papers) and Nanoparticle-Based Drug Delivery (7 papers). The work is most often cited by research in Cancer Research (536 citations), Molecular Biology (838 citations) and Oncology (322 citations). Fangfang Shi has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jun Dou, Xiaoying Wang, Kai Cai, Yunxia Zhang, Jing Wang, Hongyi Zhang, Kai Cheng, Longwei Jiang, Junsong Chen and Di Wu. Their work appears in journals such as Journal of Biological Chemistry, Blood and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.